3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Anus Neoplasms
3
Squamous Intraepithelial Lesions
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Neuroblastoma
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Gallbladder Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Bile Duct Neoplasms
2
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Smoldering Multiple Myeloma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Precancerous Conditions
1
Pleuropulmonary blastoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Interventions
Doxorubicin
6
Vincristine
4
Liposomes
4
Bleomycin
4
Fluorouracil
2
sargramostim
1
liposomal doxorubicin
1
Zidovudine
1
Watchful Waiting
1
Radiotherapy
1
Paclitaxel
1
Observation
1
Methotrexate
1
Light Coagulation
1
Leucovorin
1
Laser Therapy
1
Isotretinoin
1
Imiquimod
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Acquired Immunodeficiency Syndrome
×
Watchful Waiting
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts